Immunological parameters as a new lead in the diagnosis of ovarian cancer

被引：0
|
作者：
Baert, T. [1 ,2 ]
Timmerman, D. [1 ,3 ]
Vergote, I. [1 ,2 ]
Coosemans, A. [1 ,2 ]
机构：
[1] UZ Leuven, Gynaecol & Obstet, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Oncol, Leuven Canc Inst, B-3000 Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Dev & Regenerat, B-3000 Leuven, Belgium
来源：
FACTS VIEWS AND VISION IN OBGYN | 2015年 / 7卷 / 01期
基金：
比利时弗兰德研究基金会;
关键词：
Ovarian cancer; diagnosis; prognostic marker; immunosuppression; regulatory T cell; myeloid derived suppressor cells; tumor-associated macrophages;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ovarian cancer are being searched for. The study of the immune system as a valuable parameter in the development of ovarian cancer has been neglected for a long time. Nevertheless, this is a field in full progression and might open new perspectives in the diagnosis and prognosis of ovarian cancer patients and could lead to a more motivated choice of targeted therapies.
引用
收藏
页码：67 / 72
页数：6
相关论文
共 50 条
  • [31] Immunological and innovative forms of therapy in ovarian cancer
    Schnurch, HG
    GYNAKOLOGE, 1997, 30 (02): : 141 - 150
  • [32] An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
    Yang, Kai
    Zhao, Weiwei
    Lou, Ge
    Rong, Zhiwei
    Xu, Huan
    Wang, Wenjie
    Song, Wei
    Cai, Yuqing
    Hou, Yan
    Li, Kang
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [33] Immunological parameters of candidiasis in cancer patients
    Magrys, A
    Koziol-Montewka, M
    Staroslawska, E
    Gabczynska, B
    Szczepanik, A
    NEW MICROBIOLOGICA, 2005, 28 (04): : 355 - 364
  • [34] Immunomodulator in combination treatment of patients with ovarian cancer and its influence on DNA cytometric and immunological parameters.
    Ardzha, Anna Yu
    Verenikina, Ekaterina V.
    Zlatnik, Elena Yu
    Nikitina, Vera P.
    Zhenilo, Oksana E.
    Nikitin, Ivan S.
    Kit, Oleg, I
    Dzhenkova, Elena A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] IMMUNOLOGICAL DIAGNOSIS OF BREAST-CANCER
    SLOSS, AM
    HUBAY, CA
    POWELL, AE
    SURGICAL FORUM, 1976, 27 : 99 - 100
  • [36] IMMUNOLOGICAL APPROACHES TO DIAGNOSIS AND TREATMENT OF CANCER
    HIRSHAUT, Y
    NEW YORK STATE JOURNAL OF MEDICINE, 1975, 75 (12) : 2159 - 2159
  • [37] Ovarian hemangioma: Differential diagnosis of ovarian cancer
    Hafsi, Montacer
    Moussi, Marwa
    Najar, Souhir
    Dridi, Faten
    Maroua, Smaoui
    Mourali, Mechaal
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2024, 116
  • [38] New immunological tests in the diagnosis of tuberculosis
    Lagrange, P. H.
    Simonney, N.
    Herrmann, J. L.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (04) : 453 - 472
  • [39] A NEW CONCEPT OF THE IMMUNOLOGICAL DIAGNOSIS OF RUBELLA
    GRANGEOTKEROS, L
    PILLOT, J
    PRESSE MEDICALE, 1985, 14 (36): : 1864 - 1865
  • [40] BIOCHEMICAL DIAGNOSIS OF OVARIAN CANCER
    MCGOWAN, L
    DAVIS, RH
    BUNNAG, B
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 116 (06) : 760 - 768
12345